Document Detail


RNAi targeting ryanodine receptor 2 protects rat cardiomyocytes from injury caused by simulated ischemia-reperfusion.
MedLine Citation:
PMID:  20053523     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of a small interfering RNA targeting ryanodine receptor 2 (si-Ryr2) on cardiomyocytes injury following a simulated ischemia-reperfusion (I/R) were investigated. Pretreated with si-Ryr2 or ryanodine, primary cultures of neonatal rat cardiomyocytes were subjected to a protocol of simulated I/R. Compared with control, the cytosolic Ca(2+) concentration ([Ca(2+)](i)) and the generation of reactive oxygen species (ROS) was significantly augmented after I/R. Concomitant with these, cell injury assessed by Annexin V/PI staing, mitochondria membrane potential (DeltaPsim) and the leakage of lactic dehydrogenase (LDH) and creatine phosphokinase (CPK) were aggravated. Si-Ryr2 treatment reduced [Ca(2+)](i) and ROS generation and protected the cardiomyocytes from subsequent I/R injury, as evidenced by stable DeltaPsim and decreased Annexin V(+) PI(-) staing and enzymes release. Moreover, si-Ryr2 exerted more effective protection on I/R injury compared to ryanodine. The present study demonstrated for the first time that in neonatal cardiomyocytes, si-Ryr2 reduces cell death associated with attenuating [Ca(2+)](i) and ROS production. Furthermore, we attempt to speculate that si-Ryr2 excel ryanodine in Ryr2 function research of cardioprotection.
Authors:
Zhuying Guo; Shiting Wang; Qiang Jiao; Manghua Xu; Fenghou Gao
Related Documents :
1284153 - Calcium antagonists and experimental myocardial ischemia reperfusion injury.
7614723 - 23na and 31p nuclear magnetic resonance studies of ischemia-induced ventricular fibrill...
4226693 - Effects of chondroitin sulphates on mineralization in vitro.
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-11-18
Journal Detail:
Title:  Biomedicine & pharmacotherapy = Biom?decine & pharmacoth?rapie     Volume:  64     ISSN:  1950-6007     ISO Abbreviation:  Biomed. Pharmacother.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-12     Completed Date:  2010-06-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8213295     Medline TA:  Biomed Pharmacother     Country:  France    
Other Details:
Languages:  eng     Pagination:  184-90     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2009 Elsevier Masson SAS. All rights reserved.
Affiliation:
Experimental Center, No. 3 People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine, No. 280 Mohe Road, Baoshan District, Shanghai, China. zyguoo@126.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apoptosis / drug effects
Calcium Signaling / drug effects*,  physiology
Carbon Dioxide / pharmacology
Cells, Cultured / drug effects
Membrane Potential, Mitochondrial / drug effects
Mitochondria, Heart / drug effects
Myocardial Reperfusion Injury / prevention & control*
Myocytes, Cardiac / drug effects*
Nitrogen / pharmacology
Oxygen / pharmacology
RNA Interference*
RNA, Small Interfering / pharmacology*
Rats
Rats, Sprague-Dawley
Reactive Oxygen Species / metabolism
Ryanodine / pharmacology
Ryanodine Receptor Calcium Release Channel / biosynthesis,  drug effects*,  genetics,  physiology
Chemical
Reg. No./Substance:
0/RNA, Small Interfering; 0/Reactive Oxygen Species; 0/Ryanodine Receptor Calcium Release Channel; 124-38-9/Carbon Dioxide; 15662-33-6/Ryanodine; 7727-37-9/Nitrogen; 7782-44-7/Oxygen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Validity of the T-ACE in pregnancy in predicting child outcome and risk drinking.
Next Document:  Modulation of impact of high fat diet in pathological and physiological left ventricular cardiac hyp...